EMEA-002749-PIP01-19
Key facts
| Active substance |
Adrenaline (epinephrine)
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0431/2020
|
| PIP number |
EMEA-002749-PIP01-19
|
| Pharmaceutical form(s) |
Nasal spray, solution
|
| Condition(s) / indication(s) |
Treatment of allergic reactions
|
| Route(s) of administration |
Nasal use
|
| Contact for public enquiries |
ARS Pharmaceuticals IRL, Limited
E-mail: richardl@ars-pharma.com
Tel: +1 8583351300 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|